Back
Adaptimmune Therapeutics PLC Vs. Mereo BioPharma Group PLC Industry Stock Comparison
Buy
64
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.19
Seasonality Move:
-1.36%
Buy
83
MREO
Mereo BioPharma Group PLC
Last Price:
3.26
Seasonality Move:
63.11%
Buy
64
Adaptimmune Therapeutics PLC (ADAP)
is a Buy
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.24. The Score for ADAP is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ADAP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
83
Mereo BioPharma Group PLC (MREO)
is a Buy
Is Mereo BioPharma Group PLC a Buy, Sell or Hold?
- The current Mereo BioPharma Group PLC [MREO] share price is $3.17. The Score for MREO is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- MREO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.24
The current trend is relatively stagnant and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
MREO Stock Price Chart
What is Mereo BioPharma Group PLC's stock price today?
-
The Mereo BioPharma Group PLC share price today is $3.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MREO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 55.23 | Buy |
| Chaikin Money Flow: | 809941 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.2) | Buy |
| Bollinger Bands (100): | (0.85 - 1.47) | Buy |
MREO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 55.24 | Buy |
| Chaikin Money Flow: | 546347 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.69 - 3.11) | Buy |
| Bollinger Bands (100): | (2.69 - 3.69) | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.15 | Buy |
| 20-day SMA: | 1.12 | Buy |
| 50-day SMA: | 1.29 | Sell |
| 200-day SMA: | 0.91 | Buy |
| 8-day EMA: | 1.16 | Buy |
| 20-day EMA: | 1.16 | Buy |
| 50-day EMA: | 1.2 | Buy |
| 200-day EMA: | 1.09 | Buy |
MREO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.07 | Buy |
| 20-day SMA: | 2.96 | Buy |
| 50-day SMA: | 3.07 | Buy |
| 200-day SMA: | 2.42 | Buy |
| 8-day EMA: | 3.06 | Buy |
| 20-day EMA: | 3.02 | Buy |
| 50-day EMA: | 3.06 | Buy |
| 200-day EMA: | 2.56 | Buy |
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.08 per share.
Mereo BioPharma Group PLC Earnings Growth & MREO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.04 per share.
Adaptimmune Therapeutics PLC Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mereo BioPharma Group PLC Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||